全文获取类型
收费全文 | 2453篇 |
免费 | 193篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 202篇 |
妇产科学 | 35篇 |
基础医学 | 313篇 |
口腔科学 | 119篇 |
临床医学 | 250篇 |
内科学 | 515篇 |
皮肤病学 | 50篇 |
神经病学 | 66篇 |
特种医学 | 477篇 |
外科学 | 159篇 |
综合类 | 40篇 |
预防医学 | 164篇 |
眼科学 | 32篇 |
药学 | 139篇 |
中国医学 | 4篇 |
肿瘤学 | 102篇 |
出版年
2022年 | 9篇 |
2021年 | 19篇 |
2020年 | 22篇 |
2019年 | 15篇 |
2018年 | 22篇 |
2017年 | 18篇 |
2016年 | 29篇 |
2015年 | 45篇 |
2014年 | 51篇 |
2013年 | 86篇 |
2012年 | 66篇 |
2011年 | 76篇 |
2010年 | 103篇 |
2009年 | 77篇 |
2008年 | 75篇 |
2007年 | 64篇 |
2006年 | 77篇 |
2005年 | 63篇 |
2004年 | 57篇 |
2003年 | 46篇 |
2002年 | 41篇 |
2001年 | 47篇 |
2000年 | 47篇 |
1999年 | 47篇 |
1998年 | 146篇 |
1997年 | 122篇 |
1996年 | 134篇 |
1995年 | 99篇 |
1994年 | 80篇 |
1993年 | 86篇 |
1992年 | 35篇 |
1991年 | 36篇 |
1990年 | 37篇 |
1989年 | 80篇 |
1988年 | 58篇 |
1987年 | 61篇 |
1986年 | 58篇 |
1985年 | 62篇 |
1984年 | 36篇 |
1983年 | 39篇 |
1982年 | 37篇 |
1981年 | 25篇 |
1980年 | 41篇 |
1979年 | 24篇 |
1978年 | 20篇 |
1977年 | 18篇 |
1976年 | 26篇 |
1975年 | 26篇 |
1973年 | 13篇 |
1969年 | 8篇 |
排序方式: 共有2668条查询结果,搜索用时 15 毫秒
41.
目的:探讨输尿管硬镜在尿路疾病治疗中的应用效果。方法:对1000例尿路结石、输尿管及尿道狭窄、输尿管息肉、梗阻、异物存留等患者,均以输尿管硬镜配合其他设备进行治疗。结果:肾内结石34例治愈率76.5%,输尿管结石、膀胱及尿道结石治愈率为94.5%~99.8%;泌尿道狭窄治愈率66.7%~75%;33例泌尿道异物取出率97%。结论:基层医院在尿路疾病治疗中,根据病变的不同部位,将输尿管硬镜灵活配合现有并不高档的设备,同样可以取得较好的微创手术效果。 相似文献
42.
43.
In the 50 years since the first edition of this journal, operative paediatric surgery has undergone radical change. Many of the most common instruments are unchanged, both as a testament to their utility and in recognition of past surgeons remembered eponymously. Surrounding that basic core of instruments, theatre has changed radically as new tools and techniques have arisen. Surgeons have come down from their pedestals, recognising surgery as a team sport rather than a solo performance. More than half of the current paediatric surgical trainees are women, a higher proportion than in any other craft group of the Royal Australasian College of Surgeons. The appearance, and rapid development, of laparoscopy is to many observers the most notable change in surgery over the last 50 years. Placed in its context though, it is simply the most prominent example of a frameshift in surgical thinking. The patient as a whole is now the focus, rather than just the disease. Recent developments are as much about minimising harm to normal tissues as they are about extirpating pathology. As a surgical maxim, ‘Primum non nocere’ is even more in evidence in 2015 than it was in 1965. 相似文献
44.
45.
46.
Intra-arterial tissue adhesive for medical splenectomy in humans 总被引:2,自引:0,他引:2
47.
Jelinek J; Fairbairn LJ; Dexter TM; Rafferty JA; Stocking C; Ostertag W; Margison GP 《Blood》1996,87(5):1957-1961
A human O6-alkylguanine-DNA-alkyltransferase (ATase) cDNA-containing retrovirus was used to infect murine long-term primary bone marrow cultures. High levels of ATase expression were obtained, and colony- forming cells of the granulocyte-macrophage lineage from the cultures transduced with the human ATase retrovirus were three times more resistant to the alkylating agent, N-methyl-N-nitrosourea (MNU), than control cultures. Furthermore, expression of the human ATase protected long-term hematopoiesis, measured as the output of progenitor cells to the nonadherent fraction of the culture, against the cytotoxic effects of repeated exposures to MNU. These results clearly show that a human ATase cDNA-containing retrovirus can be used to infect long-term primary bone marrow cultures and that this attenuates their sensitivity to nitrosoureas. 相似文献
48.
Caterina Montani Carola Canella Adam J. Schwarz Jennifer Li Gary Gilmour Alberto Galbusera Keith Wafford Daniel Gutierrez-Barragan Andrew McCarthy David Shaw Karen Knitowski David McKinzie Alessandro Gozzi Christian Felder 《Neuropsychopharmacology》2021,46(6):1194
Cholinergic drugs acting at M1/M4 muscarinic receptors hold promise for the treatment of symptoms associated with brain disorders characterized by cognitive impairment, mood disturbances, or psychosis, such as Alzheimer’s disease or schizophrenia. However, the brain-wide functional substrates engaged by muscarinic agonists remain poorly understood. Here we used a combination of pharmacological fMRI (phMRI), resting-state fMRI (rsfMRI), and resting-state quantitative EEG (qEEG) to investigate the effects of a behaviorally active dose of the M1/M4-preferring muscarinic agonist xanomeline on brain functional activity in the rodent brain. We investigated both the effects of xanomeline per se and its modulatory effects on signals elicited by the NMDA-receptor antagonists phencyclidine (PCP) and ketamine. We found that xanomeline induces robust and widespread BOLD signal phMRI amplitude increases and decreased high-frequency qEEG spectral activity. rsfMRI mapping in the mouse revealed that xanomeline robustly decreased neocortical and striatal connectivity but induces focal increases in functional connectivity within the nucleus accumbens and basal forebrain. Notably, xanomeline pre-administration robustly attenuated both the cortico-limbic phMRI response and the fronto-hippocampal hyper-connectivity induced by PCP, enhanced PCP-modulated functional connectivity locally within the nucleus accumbens and basal forebrain, and reversed the gamma and high-frequency qEEG power increases induced by ketamine. Collectively, these results show that xanomeline robustly induces both cholinergic-like neocortical activation and desynchronization of functional networks in the mammalian brain. These effects could serve as a translatable biomarker for future clinical investigations of muscarinic agents, and bear mechanistic relevance for the putative therapeutic effect of these class of compounds in brain disorders.Subject terms: Schizophrenia, Translational research, Preclinical research 相似文献
49.
50.
Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4 总被引:4,自引:0,他引:4
Leukotriene B4 (LTB4) is a potent primary stimulator of neutrophil chemotaxis, aggregation, and degranulation and induces superoxide production at higher concentrations. In order to determine whether LTB4 modulates neutrophil responses to oxidative stimuli, human neutrophils (PMNs) were incubated with LTB4 prior to stimulation with f-Met-Leu-Phe (fMLP, 10(-7) mol/L), opsonized zymosan (OZ, 250 micrograms/mL), or phorbol myristate acetate (PMA, 32 nmol/L). Superoxide (O2-) production by stimulated PMNs was assessed by the superoxide dismutase-inhibitable reduction of cytochrome c. LTB4 alone did not stimulate O2- production in concentrations below 10(-7) mol/L and had no effect on the O2- assay. In the concentration range of 10(-12) to 10(-8) mol/L, LTB4 did not alter O2- release induced by OZ or PMA. In contrast, LTB4-treated cells demonstrated enhanced O2- production following exposure to fMLP, and in the presence of 10 nmol/LLTB4, generated 180% +/- 41% of O-2 quantities produced by control cells (n = 23). Enhancement was LTB4 dose-dependent, was maximal in the range of 1 to 10 nmol/L LTB4, was not reversed by removal of the lipid from the medium prior to fMLP stimulation, and was not dependent on the presence of Ca++ or Mg++ in the suspending medium. Chemiluminescence of fMLP-stimulated neutrophils was increased to 323% of controls in neutrophils preincubated with 10 nmol/L LTB4. Unlike augmentation of oxidative responses to fMLP seen with other degranulating stimuli, enhancement by LTB4 was not correlated with an increase in 3H-fMLP receptor binding. These results indicate that, in addition to its primary effects on neutrophil function, LTB4 modulates PMN oxidative responses to the chemotactic peptide and, thus, may amplify the release of oxygen metabolites at inflammatory foci. 相似文献